Calciotropic hormones and the risk of hip and nonspine fractures in older adults: The health ABC study

Journal of Bone and Mineral Research

Volumn 27, Issue 5, 2012, Pages 1177-1185

  Barbour, Kamil E ^a   Houston, Denise K ^b   Cummings, Steven R ^c   Boudreau, Robert ^a   Prasad, Tanushree ^a   Sheu, Yahtyng ^a   Bauer, Douglas C ^d   Tooze, Janet A ^b   Kritchevsky, Stephen B ^b   Tylavsky, Frances A ^e   Harris, Tamara B ^f   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f Demography and Biometry   (United States)

Author keywords

HIP FRACTURES; NONSPINE FRACTURES; PARATHYROID HORMONE; SERUM 25 HYDROXYVITAMIN D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; EDETIC ACID; PARATHYROID HORMONE;

AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL ASSESSMENT; COHORT ANALYSIS; FALLING; FEMALE; FOLLOW UP; FRACTURE; HIP FRACTURE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NONSPINE FRACTURE; PARATHYROID HORMONE BLOOD LEVEL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RADIOLOGY; RISK FACTOR; SELF REPORT; VITAMIN BLOOD LEVEL;

AGED; AGING; COHORT STUDIES; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; MALE; PARATHYROID HORMONE; RISK FACTORS; VITAMIN D;

EID: 84859912756     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1545     Document Type: Article

References (36)

1. Foulkes RG., Dietary reference intakes-calcium, phosphorus, magnesium, vitamin D, and fluoride. Fluoride. 1997; 30: 252-7.
2. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA., Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88: 1519-27.
3. Lips P., Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22: 477-501.
4. Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96: 53-8.
5. Holick MF., Vitamin D deficiency. N Engl J Med. 2007; 357: 266-81.
6. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008; 149: 242-50.
7. Cauley JA, Parimi N, Ensrud KE, et al. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res. 2010; 25: 545-53.
8. Looker AC, Mussolino ME., Serum 25-hydroxyvitamin D and hip fracture risk in older US white adults. J Bone Miner Res. 2008; 23: 143-50.
9. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med. 1998; 339: 733-8.
10. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K., Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005; 16: 1425-31.
11. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD., Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone. 2007; 40: 716-22.
12. Roddam AW, Neale R, Appleby P, Allen NE, Tipper S, Key TJ., Association between plasma 25-hydroxyvitamin D levels and fracture risk-the EPIC-Oxford study. Am J Epidemiol. 2007; 166: 1327-36.
13. Melhus H, Snellman G, Gedeborg R, et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab. 2010; 95: 2637-45.
14. Robinson-Cohen C, Katz R, Hoofnagle AN, et al. Mineral metabolism markers and the long-term risk of hip fracture: the Cardiovascular Health Study. J Clin Endocrinol Metab. 2011; 96: 2186-93.
15. van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P., Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone. 2008; 42: 260-6.
16. Lai JKC, Lucas RM, Clements MS, Roddam AW, Banks E., Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health. 2010; 10: 331.
17. Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004; 33: 589-95.
18. Semba RD, Garrett E, Johnson BA, Guralnik JM, Fried LP., Vitamin D deficiency among older women with and without disability. Am J Clin Nutr. 2000; 72: 1529-34.
19. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003; 18: 343-51.
20. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P., Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994; 10: 405-11.
21. Newman AB, Boudreau RM, Naydeck BL, Fried LF, Harris TB., A physiologic index of comorbidity: relationship to mortality and disability. J Gerontol A Biol Sci Med Sci. 2008; 63 (6): 603-9.
22. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci. 2001; 56: M644-9.
23. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008; 51: 395-406.
24. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004; 89: 3152-7.
25. Barbour KE, Zmuda JM, Horwitz MJ, et al. The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry. Osteoporos Int. 2011; 22: 2475-85.
26. Lauretani F, Bandinelli S, Russo CR, et al. Correlates of bone quality in older persons. Bone. 2006; 39: 915-21.
27. Duan Y, De L V, Seeman E., Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab. 1999; 84: 718-22.
28. Cantorna MT, Zhu Y, Froicu M, Wittke A., Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004; 80: 1717S-20S.
29. Miller RR, Hicks GE, Shardell MD, et al. Association of serum vitamin D levels with inflammatory response following hip fracture: the Baltimore Hip Studies. J Gerontol A Biol Sci Med Sci. 2007; 62: 1402-6.
30. Cauley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007; 22: 1088-95.
31. Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, LaCroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA., Inflammatory markers and the risk of hip fracture: The women's health initiative. J Bone Miner Res. 2012 Jan 27. DOI: 10.1002/jbmr.1559 [Epub ahead of print].
32. Boonen S, Broos P, Verbeke G, et al. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. J Gerontol A Biol Sci Med Sci. 1997; 52: M286-93.
33. Sakuma M, Endo N, Oinuma T, et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int. 2006; 17: 1608-14.
34. Bischoff-Ferrari HA., The 25-hydroxyvitamin D threshold for better health. J Steroid Biochem Mol Biol. 2007; 103: 614-9.
35. Cauley JA, Danielson ME, Boudreau R, Barbour KE, Horwitz MJ, Bauer DC, Ensrud KE, Manson JE, Wactawski-Wende J, Shikany JM, Jackson RD., Serum 25 hydroxyvitamin D and clinical fracture risk in a multiethnic Cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res. 2011; 26: 2378-88.
36. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E., Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004; 15: 255-65.